Citation Impact
Citing Papers
North of England evidence based guidelines development project: summary version of evidence based guideline for the primary care management of asthma in adults: Fig 1
1996
Budesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol
2006
Efficacy, Safety, and Effects on Quality of Life of Salmeterol Versus Albuterol in Patients with Mild to Moderate Persistent Asthma
1998
Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease
1998
A comparison of the efficacy and safety of inhaled corticosteroids in asthma
1997
Rescue Use of Beclomethasone and Albuterol in a Single Inhaler for Mild Asthma
2007
Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry
2002 Standout
Comparative effectiveness of long term drug treatment strategies to prevent asthma exacerbations: network meta-analysis
2014
Budesonide and Formoterol in a Single Inhaler Improves Asthma Control Compared With Increasing the Dose of Corticosteroid in Adults With Mild-to-Moderate Asthma
2003
Safety of formoterol by Turbuhaler® as reliever medication compared with terbutaline in moderate asthma
2002
Antithetic regulation by β-adrenergic receptors of Gq receptor signaling via phospholipase C underlies the airway β-agonist paradox
2003 StandoutNobel
Salmeterol Powder Provides Significantly Better Benefit Than Montelukast in Asthmatic Patients Receiving Concomitant Inhaled Corticosteroid Therapy
2001
Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease
1998
Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA)
2000
Results of a Home-Based Environmental Intervention among Urban Children with Asthma
2004 Standout
Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies
2004
Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma
2004
Effect of long‐acting β2 agonists on exacerbation rates of asthma in children
2003
Long-Acting β2-Adrenoceptor Agonists Synergistically Enhance Glucocorticoid-Dependent Transcription in Human Airway Epithelial and Smooth Muscle Cells
2007
Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial
2004
Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma
1997 Standout
Development and validation of a questionnaire to measure asthma control
1999 Standout
Asthma
2017 Standout
Impact of preventing exacerbations on deterioration of health status in COPD
2004 Standout
Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial
2003
Two first-line therapies in the treatment of mild asthma: use of peak flow variability as a predictor of effectiveness
1999
Long-Acting β<SUB>2</SUB>-Agonist Monotherapy vs Continued Therapy With Inhaled Corticosteroids in Patients With Persistent Asthma<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2001
Long-acting ?2-agonists in management of childhood asthma: A critical review of the literature
2000
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Inhaled and nasal corticosteroids Factors affecting the risks of systemic adverse effects
1999
A Holy Grail of asthma management: toward understanding how long‐acting β2‐adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids
2007
COMPARISON OF THEOPHYLLINE AND ENPROFYLLINE EFFECTS ON HUMAN NEUTROPHIL SUPEROXIDE PRODUCTION
1990
Fluticasone propionate does not influence bone metabolism in contrast to beclomethasone dipropionate.
1996
Asthma
2001 Standout
Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma
1997
Advair: Combination treatment with fluticasone propionate/salmeterol in the treatment of asthma
2001
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Formoterol (OXIS®) Turbuhaler® as a rescue therapy compared with salbutamol pMDI plus spacer in patients with acute severe asthma
2003
Scientific rationale for inhaled combination therapy with long-acting β2-agonists and corticosteroids
2002
Asthma phenotypes: the evolution from clinical to molecular approaches
2012 Standout
Stepping down inhaled corticosteroids in asthma: randomised controlled trial
2003
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial
2003
Methods for evaluation of medication adherence and persistence using automated databases
2006 Standout
The Pathophysiology and Treatment of Sepsis
2003 Standout
Indoles as therapeutics of interest in medicinal chemistry: Bird's eye view
2017 Standout
Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years
2008
A Comparison of Low-Dose Inhaled Budesonide plus Theophylline and High-Dose Inhaled Budesonide for Moderate Asthma
1997
Psychological Stress and the Human Immune System: A Meta-Analytic Study of 30 Years of Inquiry.
2004 Standout
Risk-Benefit Assessment of Fluticasone Propionate in the Treatment of Asthma and Allergic Rhinitis
1998
Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP
2002 Standout
Interactions between commensal intestinal bacteria and the immune system
2004 Standout
Inhaled Corticosteroid Reduction and Elimination in Patients With Persistent Asthma Receiving Salmeterol<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2001
Airway Subsensitivity with Long-Acting ??2-Agonists Is There Cause for Concern?
1997
Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma
2005
Asthma
2000 Standout
Zafirlukast Improves Asthma Control in Patients Receiving High-Dose Inhaled Corticosteroids
2000
Safety and Efficacy of Fluticasone and Beclomethasone in Moderate to Severe Asthma
1998
Combination Therapy with a Long-Acting β-Agonist and a Leukotriene Antagonist in Moderate Asthma
2006
Montelukast Added to Inhaled Beclomethasone in Treatment of Asthma
1999
Benefits from Adding the 5-Lipoxygenase Inhibitor Zileuton to Conventional Therapy in Aspirin-intolerant Asthmatics
1998
Oxidative Stress in Chronic Obstructive Pulmonary Disease
1997 Standout
A Long-term Study of the Antiinflammatory Effect of Low-dose Budesonide Plus Formoterol versus High-dose Budesonide in Asthma
2000
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Asthma
2005
Addition of Salmeterol versus Doubling the Dose of Beclomethasone in Children with Asthma
1998
Lack of Subsensitivity to Albuterol After Treatment with Salmeterol in Patients with Asthma
1999
Improvement of Aspirin-Intolerant Asthma by Montelukast, a Leukotriene Antagonist
2002
Low Dose Inhaled Budesonide and Formoterol in Mild Persistent Asthma
2001
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma
2003
Guidelines for management of asthma at primary and secondary levels of health care in India (2005).
2005
Extracting Value from Their Environment: Some Observations on Pimping and Prostitution as Entrepreneurship
2009
Canadian Asthma Consensus Conference Summary of Recommendations
1996
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Full publication of results initially presented in abstracts
2007 Standout
Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis
2014 Standout
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Antithetic regulation by β-adrenergic receptors of Gq receptor signaling via phospholipase C underlies the airway β-agonist paradox
2003 StandoutNobel
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature
2001
Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast
2000
Use of Inhaled Corticosteroids and Risk of Fractures
2001 Standout
The impact of training informal health care providers in India: A randomized controlled trial
2016 StandoutScienceNobel
Metered dose inhalers and spacer devices.
2000
Modelling the critical success factors of women entrepreneurship using fuzzy AHP framework
2018 Standout
Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children
2012
Works of N Ringdal being referenced
A Placebo-controlled Dose-Response Study of Enprofylline in the Maintenance Therapy of Asthma
1989
A comparison of fluticasone propionate 200 μg/day with beclomethasone dipropionate 400 μg/day in adult asthma
1994
Salmeterol and Fluticasone Propionate (50/250 μg) Administered via Combination Diskus Inhaler: As Effective as When Given via Separate Diskus Inhalers
1999
Onset and duration of action of single doses of formoterol inhaled via turbuhaler®
1998
Evaluation of different inhaled combination therapies (EDICT): a randomised, double-blind comparison of SeretideTM (50/250 μg bd DiskusTM vs. formoterol (12 μg bd) and budesonide (800 μg bd) given concurrently (both via TurbuhalerTM) in patients with moderate-to-severe asthma
2002
A 3-Month Comparison of Formoterol with Terbutaline via Turbuhaler. A Placebo-Controlled Study
1998
The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma
2003
Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids.
1996
Low-dose formoterol Turbuhaler® (Oxis®) b.i.d., a 3-month placebo-controlled comparison with terbutaline (q.i.d.)
1998
Bambuterol: a new long acting bronchodilating prodrug.
1991
EQUIVALENCE OF ASTHMA CONTROL WITH NEW CFC‐FREE FORMULATION HFA‐134a BECLOMETHASONE DIPROPIONATE AND CFC‐BECLOMETHASONE DIPROPIONATE
1997
Love For Sale: A World History of Prostitution
2003